Saturday, October 5, 2019 at 7:00am to 4:00pm
Aresty Conference Center (NRT)
1450 Biggy Street, Los Angeles, CA 90033
This course presents an annual update of major advances in the treatment of cerebrovascular disease. Highlights of the morning session include expanding the role of venous sinus stenting for idiopathic intracranial hypertension (pseudotumor cerebri), tinnitus, and other conditions. Additional presentations focus on novel approaches of the USC Intracerebral Hemorrhage (ICH) program, such as embolization of the middle meningeal artery to treat chronic subdural hematoma, minimally invasive resection of ICH, and the benefit of a microsurgical bypass to mitigate ICH in moyamoya patients.
The keynote presentation addresses challenges of building the multidisciplinary stroke center of the future. The afternoon session highlights best practices for medical treatment of the intracranial hemorrhage, including prehospital, Emergency Department, and ICU management. The program concludes with dilemmas in stroke neurology such as prevention of ICH, non-aneurysmal subarachnoid hemorrhage and cerebral microbleeds. The program is structured to be highly interactive with case presentations, panel discussions, and question and answer sessions. Audience participation is encouraged.